On April 12, 2024, a panel of the Inquiry Committee approved a consent agreement between BCCNM and Amaris Foster of Kamloops, B.C., to address practice deficits that occurred on March 5, 2023, related to administering hydromorphone 24 mg SR to the wrong patient.
The registrant has voluntarily agreed to terms equivalent to a limit and/or condition on their practice, including:
A limit prohibiting them from being the sole LPN on duty, working nightshift or overtime, from providing regulatory supervision to nursing students and other regulated health professionals, and from providing orientation to new staff members.
The registrant will complete education related to medication administration.
The Agreement will remain in place for a maximum of nine months of continuous nursing practice.
The Inquiry Committee is satisfied that the terms will protect the public.